- In April 2023, Olympus Corporation launched the QuickClip Pro hemostatic clip in multiple global markets, designed to improve precision and control during endoscopic procedures. This new clip enables rapid deployment and enhanced rotation control, supporting improved outcomes in gastrointestinal bleeding management. The innovation reflects Olympus’ commitment to advancing therapeutic endoscopy and expanding its portfolio of high-performance hemostasis solutions
- In March 2023, Boston Scientific Corporation introduced its next-generation Resolution 360 ULTRA Clip in the U.S. and Europe, engineered to provide superior rotation and grip force for complex GI bleeding scenarios. This upgrade enhances procedural efficiency and clinical accuracy, underlining Boston Scientific’s continued focus on device innovation and meeting the evolving needs of endoscopists worldwide
- In March 2023, Cook Medical announced expanded availability of its Instinct Plus Endoscopic Hemoclip, which offers enhanced opening width and repositioning capabilities to support a broader range of GI bleeds. The device’s improved visibility and anchoring features help clinicians manage difficult bleeds with greater ease and precision. This development illustrates Cook Medical’s dedication to simplifying complex endoscopic interventions
- In February 2023, CONMED Corporation revealed advancements to its Beamer Platform, incorporating optimized argon plasma coagulation (APC) settings and safety features tailored for therapeutic endoscopy. The platform upgrade facilitates improved energy delivery and tissue interaction, enabling consistent coagulation in a range of GI bleeding cases. This reinforces CONMED’s role in delivering cutting-edge energy-based hemostasis technologies
- In January 2023, ERBE Elektromedizin GmbH showcased its latest VIO 3 electrosurgical unit and APC 3 system at the Arab Health 2023 conference, emphasizing greater user customization, intuitive controls, and integration with high-frequency endoscopy tools. These innovations are aimed at advancing GI therapeutic procedures through greater precision and safety. The launch highlights ERBE’s continued investment in thermal hemostasis technologies to support global endoscopic practices
